查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827818

2025年全球醫療仿生植入/人工器官市場報告

Medical Bionic Implant/Artificial Organs Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，醫療仿生植入/人工器官市場規模強勁成長，從2024年的237.1億美元成長至2025年的252.2億美元，複合年成長率為6.3%。這段歷史時期的成長可歸因於老年人口的成長、材料科學的進步、政府的支持和資助、植入式設備的接受度不斷提高以及患者意識的提升和相關教育的加強。

預計未來幾年，醫療仿生植入/人工器官市場將強勁成長，到2029年將達到343.8億美元，複合年成長率為8.1%。預測期內的成長可歸因於生物列印和組織工程、生物混合植入的興起、對心臟仿生學的關注、增強型感覺回饋以及仿生學中的再生醫學。預測期內的主要趨勢包括矯正器具和矯正器具的進步、對腦機介面 (BMIS) 的日益關注、用於移植的仿生器官、仿生植入的3D列印、人工智慧 (AI) 的整合、無線連接和遠端監控。

醫療仿生植入物/植入器官包括用於複製受損或缺失的器官或身體部位功能的設備和機器。這些技術創新旨在幫助殘疾人恢復身體功能，包括增強心臟和神經功能的植入等。

在醫療仿生植入和人工器官領域，主要分為兩類：仿生植入和人工器官。仿生植入由電子或機電元件組成，旨在增強或恢復殘障人士的身體功能。這些植入採用電子和/或機械技術，固定方式多種多樣，包括植入式和外戴式。這些植入廣泛應用於醫院、診所、研究機構和學術機構等各種場所。

2025年春季，美國關稅上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供醫療仿生植入/人工器官市場統計數據，包括全球市場規模、各地區市場佔有率、競爭對手的醫療仿生植入物/人工器官植入/人工器官細分市場、市場趨勢和商機，以及您在仿生生物/植入/器官的行業取得成功所需的人工器官。本醫療仿生植入/人工器官市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整觀點。

未來五年8.1%的預測成長率，較我們先前對該市場的預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。這種影響將透過對瑞士生物材料和微處理器的限制直接波及美國，這可能會減緩創新並增加用於改善生活矯正器具的成本。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛。

預計交通事故和傷害的增加將在未來幾年推動醫療仿生植入和人造器官市場的成長。交通事故是指在公共道路上發生的導致受害者受傷的事故。人造器官和組織替換主要用於修復因車禍、暴力犯罪、工業事故和難產等創傷性事件造成的器官損傷。例如，2022 年 5 月，美國負責交通安全的聯邦機構國家公路交通安全管理局 (NHTSA) 報告機動車事故死亡人數增加了 10.5%，估計約有 42,915 人死亡，而前兩年為 38,824 人。因此，交通事故和傷害的增加正在推動醫療仿生植入和人造器官市場的擴張。

慢性病的增加推動了醫療仿生植入和人工器官產業的成長。病程超過三個月的慢性病越來越普遍，這使得使用醫療仿生植入和人工器官來治療糖尿病等疾病成為必要。例如，美國國家醫學圖書館預測，到2050年，美國50歲以上至少患有一種慢性病的人數將增加99.5%。此外，正如世界衛生組織（WHO）在2022年9月所強調的那樣，全球每年約有4,100萬人死於非傳染性疾病和慢性疾病，凸顯了慢性病的流行是市場成長的驅動力。

在醫療仿生植入物和人工器官市場，策略聯盟正變得越來越普遍。許多公司正在透過建立夥伴關係來鞏固其市場地位。例如，2024年9月，美國醫療設備製造商Beta Bionics與美國醫療設備公司雅培實驗室（Abbott Laboratories）合作，將其iLet Bionic Pancreas與FreeStyle Libre 3動態血糖監測系統整合。此次合作旨在透過與雅培先進的CGM技術無縫整合，增強iLet Bionic Pancreas用戶的糖尿病管理。此外，2022年2月，專注於人工器官研究的美國研究服務公司HUMOTECH與美國義足大學密西根大學（University of Michigan）合作。此次合作旨在加速仿生腿控制軟體的開發，該軟體可為義肢使用者提供類似人類的腿部力量和自然的步態。作為此次合作的一部分，HUMOTECH正在開發其開放原始碼義肢的升級版本，以便更好地服務義足用戶和研究人員。

醫療仿生植入和人工器官市場涵蓋心律調節器、輔助人工心臟、義肢和手指、外骨骼以及心臟瓣膜的銷售。此市場的價值是指“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球醫療仿生植入/人工器官：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球醫療仿生植入/人造器官市場：成長率分析
  • 全球醫療仿生植入/人工器官市場表現：規模與成長，2019-2024
  • 全球醫療仿生植入/人工器官市場預測：規模與成長，2024-2029年，2034年
  • 全球醫療仿生植入/人工器官：總目標市場（TAM）

第6章 市場細分

  • 全球醫療仿生植入/人工器官市場類型、績效及預測（2019-2024年、2024-2029年、2034年）
  • 仿生植入
  • 人造器官
  • 全球醫療仿生植入/人工器官市場（依固定方法、實際及預測），2019-2024 年、2024-2029 年、2034 年
  • 嵌入式
  • 外用
  • 全球醫療仿生植入/人工器官市場（按技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 電子的
  • 機器
  • 全球醫療仿生植入/人工器官市場：應用、績效及預測，2019-2024年、2024-2029年、2034年
  • 醫院
  • 診所
  • 研究和學術機構
  • 其他用途
  • 全球醫療仿生植入/人工器官市場：按仿生植入類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 仿生肢體
  • 仿生眼
  • 人工電子耳
  • 人造器官
  • 全球醫療仿生植入/人造器官市場：按人造器官類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 人工心臟
  • 人工腎
  • 人工肝
  • 人工胰臟

第7章 區域和國家分析

  • 全球醫療仿生植入/人工器官市場：區域分析、預測與趨勢，2019-2024 年、2024-2029 年、2034 年
  • 全球醫療仿生植入/人工器官市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 醫療仿生植入/人工器官市場：競爭格局
  • 醫療仿生植入/人工器官市場：公司簡介
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Services Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Ekso Bionics Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Cochlear Limited
  • Cyberonics Inc.
  • LivaNova PLC
  • NeuroPace Inc.
  • Ossur India Private Limited
  • Vivani Medical Inc.
  • St Jude Medical India Private Limited
  • LifeNet Health Inc.
  • Ottobock SE & Co. KGaA
  • Edwards Lifesciences India Pvt. Ltd.
  • SynCardia Systems LLC
  • Demant A/S
  • Berlin Heart GmbH
  • Conmed Devices Private Limited
  • Wright Medical Group NV

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年醫療仿生植入/人工器官市場：提供新機會的國家
  • 2029年醫療仿生植入/人工器官市場：細分領域帶來新機會
  • 2029年醫療仿生植入/人工器官市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r22767u

Medical bionic implant artificial organs encompass devices or machinery utilized to replicate the functions of a damaged or missing body organ or part. These innovations serve to restore physical capabilities to individuals facing disabilities, spanning a range of implants that notably enhance cardiac and neurological functions.

The realm of medical bionic implants and artificial organs, two primary categories exist such as bionic implants and artificial organs. Bionic implants consist of electronic or mechatronic elements designed to augment or reinstate the physical abilities of individuals with disabilities. These implants vary in fixation methods, including implantable and externally worn options, leveraging electronic and mechanical technologies. They find applications across diverse settings such as hospitals, clinics, research institutes, academic institutions, and beyond.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The medical bionic implant/artificial organs market research report is one of a series of new reports from The Business Research Company that provides medical bionic implant/artificial organs market statistics, including medical bionic implant/artificial organs industry global market size, regional shares, competitors with a medical bionic implant/artificial organs market share, detailed medical bionic implant/artificial organs market segments, market trends and opportunities, and any further data you may need to thrive in the medical bionic implant/artificial organs industry. This medical bionic implant/artificial organs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical bionic implant/artificial organs market size has grown strongly in recent years. It will grow from $23.71 billion in 2024 to $25.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increasing geriatric population, advances in materials science, government support and funding, growing acceptance of implantable devices, patient awareness and education.

The medical bionic implant/artificial organs market size is expected to see strong growth in the next few years. It will grow to $34.38 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to bioprinting and tissue engineering, emergence of biohybrid implants, focus on cardiac bionics, enhanced sensory feedback, regenerative medicine in bionics. Major trends in the forecast period include advancements in prosthetics and orthotics, increasing focus on brain-machine interfaces (BMIS), bionic organs for transplantation, 3D printing in bionic implants, integration of artificial intelligence (AI), wireless connectivity and remote monitoring.

The forecast of 8.1% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through restrictions on biocompatible materials and microprocessors from Switzerland, slowing innovation and increasing costs for life-enhancing prosthetics.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increase in road accidents and injuries is anticipated to drive the growth of the medical bionic implant and artificial organs market in the coming years. Road accidents refer to incidents on public roads that result in injuries to victims. Artificial organ and tissue replacements are performed to address organ damage primarily caused by traumatic events such as vehicle accidents, violent crimes, work-related injuries, or difficult births. For example, in May 2022, the National Highway Traffic Safety Administration (NHTSA), a US federal government agency focused on transportation safety, reported a 10.5% rise in motor vehicle crash fatalities, estimating approximately 42,915 deaths compared to 38,824 over the previous two years. Consequently, the increase in road accidents and injuries is driving the expansion of the medical bionic implant and artificial organs market.

The increasing prevalence of chronic diseases is poised to propel growth within the medical bionic implant and artificial organs sector. Chronic diseases persisting for three months or more are becoming more widespread, necessitating the use of medical bionic implants and artificial organs to manage conditions like diabetes. For example, projections from the National Library of Medicine indicate a 99.5% increase in individuals aged 50 and above with at least one chronic condition in the US by 2050. Moreover, as highlighted in September 2022 by the World Health Organization, approximately 41 million deaths each year globally are attributed to noncommunicable diseases or chronic ailments, emphasizing the market growth driven by the mounting prevalence of chronic diseases.

Strategic partnerships are becoming a prominent trend in the medical bionic implant and artificial organs market. Many companies in this sector are forming partnerships to strengthen their market positions. For example, in September 2024, Beta Bionics, a US-based medical equipment manufacturing company, collaborated with Abbott Laboratories, a US-based medical device firm, to integrate the iLet Bionic Pancreas with the FreeStyle Libre 3 continuous glucose monitoring (CGM) system. This collaboration aims to enhance diabetes management for users of the iLet Bionic Pancreas by providing seamless integration with Abbott's advanced CGM technology. Additionally, in February 2022, HUMOTECH, a US-based research services company focused on artificial organs, partnered with the University of Michigan, a public research university in the US. This partnership seeks to accelerate the development of bionic leg control software, which could provide prosthetic users with the strength and natural gait of a human leg. As part of this collaboration, HUMOTECH is developing updated versions of the open-source leg to better serve prosthesis users and researchers.

Major players in the medical bionic implant and artificial organs market are leveraging CAD and 3D printing technologies to gain a competitive edge. Utilizing Computer-Aided Design (CAD) and 3D printing technologies allows for precise customization and rapid prototyping of medical bionic implants, particularly in crafting artificial organs. For instance, CureTech's launch of the Polyether ether ketone (PEEK) cranial implant in April 2022 demonstrates the application of CAD software and 3D printing to create a biocompatible implant used in orthopedic applications like spinal fusion, joint replacement, and trauma surgery.

In May 2022, LivaNova PLC, a UK-centered medical device manufacturer, completed the acquisition of ALung Technologies, Inc., for an undisclosed sum. Foreseen to maintain a neutral impact on adjusted diluted earnings per share in 2022, this move signifies LivaNova's commitment to strategic portfolio investments. It includes the phased release of the next-generation heart-lung machine, Essenz, and the broadened applications in advanced circulatory procedures. ALung Technologies Inc., situated in the United States, specializes in the production of artificial organs.

Major companies operating in the medical bionic implant/artificial organs market are Medtronic PLC, Boston Scientific Services Private Limited., Abbott Laboratories Inc., Zimmer Biomet Holdings Inc., Ekso Bionics Holdings Inc., Cochlear Limited, Cyberonics Inc., LivaNova PLC, NeuroPace Inc., Ossur India Private Limited, Vivani Medical Inc., St Jude Medical India Private Limited, LifeNet Health Inc., Ottobock SE & Co. KGaA, Edwards Lifesciences India Pvt. Ltd., SynCardia Systems LLC, Demant A/S, Berlin Heart GmbH, Conmed Devices Private Limited, Wright Medical Group N.V., Abiomed Inc., Baxter Laboratories Inc., Asahi Kasei Medical Co. Ltd., Getinge AB, Bornlife Prosthetic and Orthotic Inc., Sonova Holding AG, Biocontrol Medical Ltd., Orthofix International Inc., Aleva Neurotherapeutics SA, Second Sight Medical Products Inc., Touch Bionics Inc., Thoratec Corporation, CardiacAssist Inc., HeartWare International Inc., Synapse Biomedical Inc., Neurotech NA Inc., Retina Implant AG, Advanced Bionics AG, Med-El Elektromedizinische Gerate GmbH

Asia-Pacific was the largest region in the medical bionic implant/artificial organs market share in 2024. The regions covered in the medical bionic implant/artificial organs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical bionic implant/artificial organs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical bionic implant artificial organs market consists of sales of pacemakers, ventricular assist device, artificial limb and fingers, exoskeletons, heart valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Bionic Implant/Artificial Organs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical bionic implant/artificial organs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical bionic implant/artificial organs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical bionic implant/artificial organs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Bionic Implants; Artificial Organs
  • 2) By Method Of Fixation: Implantable; Externally Worn
  • 3) By Technology: Electronic; Mechanical
  • 4) By Application: Hospitals; Clinics; Research And Academic Institutes; Other Applications
  • Subsegments:
  • 1) By Bionic Implants: Bionic Limbs; Bionic Eyes; Cochlear Implants; Artificial Organs
  • 2) By Artificial Organs: Artificial Hearts; Artificial Kidneys; Artificial Livers; Artificial Pancreas
  • Companies Mentioned: Medtronic PLC; Boston Scientific Services Private Limited.; Abbott Laboratories Inc.; Zimmer Biomet Holdings Inc.; Ekso Bionics Holdings Inc.; Cochlear Limited; Cyberonics Inc.; LivaNova PLC; NeuroPace Inc.; Ossur India Private Limited; Vivani Medical Inc.; St Jude Medical India Private Limited; LifeNet Health Inc.; Ottobock SE & Co. KGaA; Edwards Lifesciences India Pvt. Ltd.; SynCardia Systems LLC; Demant A/S; Berlin Heart GmbH; Conmed Devices Private Limited; Wright Medical Group N.V.; Abiomed Inc.; Baxter Laboratories Inc.; Asahi Kasei Medical Co. Ltd.; Getinge AB; Bornlife Prosthetic and Orthotic Inc.; Sonova Holding AG; Biocontrol Medical Ltd.; Orthofix International Inc.; Aleva Neurotherapeutics SA; Second Sight Medical Products Inc.; Touch Bionics Inc.; Thoratec Corporation; CardiacAssist Inc.; HeartWare International Inc.; Synapse Biomedical Inc.; Neurotech NA Inc.; Retina Implant AG; Advanced Bionics AG; Med-El Elektromedizinische Gerate GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Bionic Implant/Artificial Organs Market Characteristics

3. Medical Bionic Implant/Artificial Organs Market Trends And Strategies

4. Medical Bionic Implant/Artificial Organs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Medical Bionic Implant/Artificial Organs Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Medical Bionic Implant/Artificial Organs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Medical Bionic Implant/Artificial Organs Market Growth Rate Analysis
  • 5.4. Global Medical Bionic Implant/Artificial Organs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Medical Bionic Implant/Artificial Organs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Medical Bionic Implant/Artificial Organs Total Addressable Market (TAM)

6. Medical Bionic Implant/Artificial Organs Market Segmentation

  • 6.1. Global Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bionic Implants
  • Artificial Organs
  • 6.2. Global Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable
  • Externally Worn
  • 6.3. Global Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electronic
  • Mechanical
  • 6.4. Global Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Research And Academic Institutes
  • Other Applications
  • 6.5. Global Medical Bionic Implant/Artificial Organs Market, Sub-Segmentation Of Bionic Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bionic Limbs
  • Bionic Eyes
  • Cochlear Implants
  • Artificial Organs
  • 6.6. Global Medical Bionic Implant/Artificial Organs Market, Sub-Segmentation Of Artificial Organs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Artificial Hearts
  • Artificial Kidneys
  • Artificial Livers
  • Artificial Pancreas

7. Medical Bionic Implant/Artificial Organs Market Regional And Country Analysis

  • 7.1. Global Medical Bionic Implant/Artificial Organs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Medical Bionic Implant/Artificial Organs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Medical Bionic Implant/Artificial Organs Market

  • 8.1. Asia-Pacific Medical Bionic Implant/Artificial Organs Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Medical Bionic Implant/Artificial Organs Market

  • 9.1. China Medical Bionic Implant/Artificial Organs Market Overview
  • 9.2. China Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Medical Bionic Implant/Artificial Organs Market

  • 10.1. India Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Medical Bionic Implant/Artificial Organs Market

  • 11.1. Japan Medical Bionic Implant/Artificial Organs Market Overview
  • 11.2. Japan Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Medical Bionic Implant/Artificial Organs Market

  • 12.1. Australia Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Medical Bionic Implant/Artificial Organs Market

  • 13.1. Indonesia Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Medical Bionic Implant/Artificial Organs Market

  • 14.1. South Korea Medical Bionic Implant/Artificial Organs Market Overview
  • 14.2. South Korea Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Medical Bionic Implant/Artificial Organs Market

  • 15.1. Western Europe Medical Bionic Implant/Artificial Organs Market Overview
  • 15.2. Western Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Medical Bionic Implant/Artificial Organs Market

  • 16.1. UK Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Medical Bionic Implant/Artificial Organs Market

  • 17.1. Germany Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Medical Bionic Implant/Artificial Organs Market

  • 18.1. France Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Medical Bionic Implant/Artificial Organs Market

  • 19.1. Italy Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Medical Bionic Implant/Artificial Organs Market

  • 20.1. Spain Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Medical Bionic Implant/Artificial Organs Market

  • 21.1. Eastern Europe Medical Bionic Implant/Artificial Organs Market Overview
  • 21.2. Eastern Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Medical Bionic Implant/Artificial Organs Market

  • 22.1. Russia Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Medical Bionic Implant/Artificial Organs Market

  • 23.1. North America Medical Bionic Implant/Artificial Organs Market Overview
  • 23.2. North America Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Medical Bionic Implant/Artificial Organs Market

  • 24.1. USA Medical Bionic Implant/Artificial Organs Market Overview
  • 24.2. USA Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Medical Bionic Implant/Artificial Organs Market

  • 25.1. Canada Medical Bionic Implant/Artificial Organs Market Overview
  • 25.2. Canada Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Medical Bionic Implant/Artificial Organs Market

  • 26.1. South America Medical Bionic Implant/Artificial Organs Market Overview
  • 26.2. South America Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Medical Bionic Implant/Artificial Organs Market

  • 27.1. Brazil Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Medical Bionic Implant/Artificial Organs Market

  • 28.1. Middle East Medical Bionic Implant/Artificial Organs Market Overview
  • 28.2. Middle East Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Medical Bionic Implant/Artificial Organs Market

  • 29.1. Africa Medical Bionic Implant/Artificial Organs Market Overview
  • 29.2. Africa Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Medical Bionic Implant/Artificial Organs Market Competitive Landscape And Company Profiles

  • 30.1. Medical Bionic Implant/Artificial Organs Market Competitive Landscape
  • 30.2. Medical Bionic Implant/Artificial Organs Market Company Profiles
    • 30.2.1. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Boston Scientific Services Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Ekso Bionics Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Medical Bionic Implant/Artificial Organs Market Other Major And Innovative Companies

  • 31.1. Cochlear Limited
  • 31.2. Cyberonics Inc.
  • 31.3. LivaNova PLC
  • 31.4. NeuroPace Inc.
  • 31.5. Ossur India Private Limited
  • 31.6. Vivani Medical Inc.
  • 31.7. St Jude Medical India Private Limited
  • 31.8. LifeNet Health Inc.
  • 31.9. Ottobock SE & Co. KGaA
  • 31.10. Edwards Lifesciences India Pvt. Ltd.
  • 31.11. SynCardia Systems LLC
  • 31.12. Demant A/S
  • 31.13. Berlin Heart GmbH
  • 31.14. Conmed Devices Private Limited
  • 31.15. Wright Medical Group N.V.

32. Global Medical Bionic Implant/Artificial Organs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Bionic Implant/Artificial Organs Market

34. Recent Developments In The Medical Bionic Implant/Artificial Organs Market

35. Medical Bionic Implant/Artificial Organs Market High Potential Countries, Segments and Strategies

  • 35.1 Medical Bionic Implant/Artificial Organs Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Medical Bionic Implant/Artificial Organs Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Medical Bionic Implant/Artificial Organs Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer